Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20180312039060N5Phase 3Completed
Phase 3, randomised, double-blind trial in nasal congestion comparing Nasonex arm with Phenylephrine control arm (2 arms). Primary endpoint: Average score of the standard SNOT-20 questionnaire. Started Jan 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20180312039060N5.